Kevin Thomas

ABOUT

Kevin Thomas

Kevin is a co-founder of Gosset, a platform that helps biotech investors and pharmaceutical corporate development analysts optimize their due diligence process. Prior to Gosset, he co-founded Saliency, a company that develops AI-enabled medical imaging biomarkers. Saliency was acquired by Clario in 2020 and he subsequently served as Clario's Director of AI. Before that, he was a researcher within the Stanford University Neuromuscular Biomechanics Lab where he leveraged AI to further the understanding of musculoskeletal diseases. Kevin has worked with some of the top organizations in health and human performance (Adidas, Philadelphia Phillies, EXOS) to advance their machine learning and biomechanics capabilities. He has a PhD in biomedical data science from Stanford University. Before attending graduate school, he conducted research in Canada as a Fulbright Scholar.

Select Work

Gosset

Biotech Investing Startup Co-Founder

Saliency

Medical Technology Startup Co-Founder

Wearables Research as a Fulbright Scholar

Basketball & Sprinting Biomechanics, AI

NBA Basketball Health Analytics

Basketball Analytics, Orthopedic Surgery

Automatic Assessment of Knee X-rays & MRIs

Computer Vision, Orthopedic Surgery, Medical Imaging

Real-Time Gait Coaching for Rehab

Computer Vision, Biomechanics, Orthopedic Surgery

Baseball Analytics @ Philadelphia Phillies

Baseball Analytics

In The Media